P3.01-033 Detection of Epidermal Growth Factor Receptor Mutations With Plasma Sample Compared With Tumor Tissue Biopsy in Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.1474
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma Cytological Specimens by Immunocytochemistry

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Rapid Detection of Epidermal Growth Factor Receptor Mutations With Multiplex PCR and Primer Extension in Lung Cancer

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2010English

Association Between Histopathological Subtype, 18f-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma

Oncology Letters
Cancer ResearchOncology
2016English

P3.01-99 Effect of Pembrolizumab on Patients Harboring Uncommon Epidermal Growth Factor Receptor Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2012English

Association of Epidermal Growth Factor Receptor Mutations With Metastatic Presentations in Non-Small Cell Lung Cancer

ISRN Oncology
2011English

Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2018English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy